The HIV Prevention Trials Network (HPTN) announced today results from HPTN 083, a global randomized, controlled, double-blind study that compared the safety and efficacy of long-acting injectable cabotegravir (CAB LA) to ...
May 19, 2020
0
8
For the first time, researchers have identified that an immune cell subset called gamma delta T cells that may be causing and/or perpetuating the systemic inflammation found in normal aging in the general geriatric population ...
Dec 11, 2018
0
665
Even though annual deaths from AIDS are coming down—from a peak of 1.9 million in 2004 to 690,000 in 2020—that's still way too many. In 2020, 214,000 people with AIDS died of tuberculosis (TB), though only about 50% were ...
Feb 10, 2022
0
3
In December, the journal Vaccines published an analysis of COVID-19 vaccination coverage among people with HIV in Catalonia between December 2020 and July 2022. The study led by the Center for Epidemiological Studies on HIV/AIDS ...
Feb 2, 2024
0
0
Cells from the rare individuals who naturally control HIV infection have been the focus of investigation for nearly 15 years with the aim of elucidating their specific features. Following research on the ANRS CO21 CODEX and ...
Jul 12, 2019
0
80
Some HIV patients are naturally able to keep the virus fully in check without any medicinal help, a phenomenon that has intrigued scientists for decades.
May 22, 2023
0
52
(HealthDay)—Prurigo nodularis (PN) is associated with mental health disorders, systemic illnesses, and HIV infection, according to a study published online Aug. 15 in the Journal of Investigative Dermatology.
Aug 23, 2019
0
11
Medications such as buprenorphine and methadone should be used to help treat patients with opioid use disorder who come to hospital with injecting-related infections, finds new research from UCL and UNSW, Sydney.
Jul 21, 2022
0
29
New annual infections with HIV fell by 73 percent from its peak in the mid-1980s to 2019, according to a new analysis by US health authorities released Thursday.
Jun 4, 2021
0
10
Instituting combination antiretroviral (ART) treatment at the earliest stages of HIV infection may allow the generation of functional CD8 "killer" T cells and preservation of the CD4 helper T cells that are the virus's primary ...
May 22, 2019
0
61
